Lomitapide and Fostamatinib: Interaction Details
- Lomitapide
- Juxtapid
- Fostamatinib
- Tavalisse
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Lomitapide and Fostamatinib interaction:
What Happens When You Take Lomitapide With Fostamatinib
What can happen when they are taken together (rated Major)
Increased lomitapide exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When lomitapide, a , is taken together with a weak CYP3A4 , lomitapide exposure may rise. With a weak CYP3A4 inhibitor, the maximum recommended lomitapide dose is 10 mg for patients aged 2 to 10 years, 20 mg for those aged 11 to 17 years, and 30 mg for those aged 18 years and older.
The schedule during of a weak CYP3A4 inhibitor depends on age. For ages 2 to 10 years, the dose moves from 2 mg (weeks 0 to 8) to 5 mg (weeks 9 to 12), then 10 mg (weeks 13 to 16), and reaches 20 mg from week 17 onward.
Doses above this are not recommended. For ages 11 to 15 years, titration starts at 2 mg (weeks 0 to 4), followed by 5 mg (weeks 5 to 8), 10 mg (weeks 9 to 12), 20 mg (weeks 13 to 16), and 40 mg from week 17 onward, and the 60 mg dose is not recommended.
For ages 16 to 17 years, the schedule is 2 mg (weeks 0 to 2), 5 mg (weeks 3 to 6), 10 mg (weeks 7 to 10), 20 mg (weeks 11 to 14), and 40 mg from week 15 onward, and again the 60 mg dose is not recommended. For patients aged 18 years and older, the titration pattern matches that of the 16 to 17 year group, but a 60 mg dose is permitted after week 15.
If a weak CYP3A4 inhibitor is started in a patient already on a stable lomitapide dosage, the lomitapide dose should be halved. Cautious titration may then be considered, guided by LDL-C response and safety/tolerability, up to half the maximum recommended dosage. The exception is coadministration with oral contraceptives only, where the maximum recommended lomitapide dose is about two thirds of the maximum recommended dose.1
The Lomitapide and Fostamatinib Interaction, Explained
Fostamatinib can raise the amount of lomitapide in your body. Lomitapide (Juxtapid), a cholesterol medicine, is broken down by an enzyme called . Fostamatinib (Tavalisse), used for low from ITP, is a weak blocker of that enzyme, so lomitapide may build up. That can mean more side effects, such as stomach upset, diarrhea, and effects on the liver.
This is a known, manageable interaction. Your care team may lower or adjust your lomitapide dose and watch your cholesterol response and tolerability. Keep taking both as prescribed and ask your pharmacist or doctor about your dose.
Mechanism: Fostamatinib (via its active R406) is a weak . Lomitapide is a CYP3A4 , so may increase lomitapide exposure (/). Evidence: probable. Onset: unspecified. Severity on file: major.
- Max lomitapide dose with a weak CYP3A4 inhibitor: 10 mg (ages 2 to 10), 20 mg (11 to 17), 30 mg (18 and older).
- If the inhibitor is started in a patient on a stable lomitapide dose, reduce the lomitapide dose by half. Then titrate carefully per LDL-C response and safety/tolerability, up to half the usual maximum.
- Exception: with oral contraceptives only, the maximum is about two thirds of the usual maximum.
- The labeled schedules for coadministration with weak are age-specific. Consult the label.
- Monitor LDL-C, tolerability ( effects), and parameters.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Lomitapide and Fostamatinib Interact
The likely mechanism
of -mediated of lomitapide
How to Manage the Lomitapide and Fostamatinib Interaction
Your care team can manage this by tailoring your lomitapide dose and monitoring you.
- If you are already on lomitapide and fostamatinib is added, your prescriber will typically reduce the lomitapide dose by half. They may then adjust it carefully based on your LDL cholesterol response and how well you tolerate it.
- There is a lower maximum lomitapide dose while you take fostamatinib. It depends on your age.
- Keep taking both medicines exactly as prescribed, and do not change doses on your own.
- Tell your pharmacist or prescriber about any new side effects, and about any oral contraceptive you use.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Lomitapide or Fostamatinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: JUXTAPID oral capsules, lomitapide oral capsules
When atorvastatin (a weak ) 80 mg daily was given together with a single 20 mg dose of lomitapide, the lomitapide rose 2-fold and its rose 2.1-fold, relative to lomitapide given alone.1
Lomitapide and Fostamatinib: Common Questions
How serious is the Lomitapide and Fostamatinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Lomitapide and Fostamatinib interaction managed?
Your care team can manage this by tailoring your lomitapide dose and monitoring you. If you are already on lomitapide and fostamatinib is added, your prescriber will typically reduce the lomitapide dose by half. They may then adjust it carefully based on your LDL cholesterol response and how well you tolerate it. There is a lower maximum lomitapide dose while you take fostamatinib. It depends on y… Management is individual — always follow your own care team's guidance.
Does taking Lomitapide and Fostamatinib at different times of day help?
No. Taking them at different times of day does not prevent this one. Fostamatinib slows , an enzyme that breaks down lomitapide, so lomitapide can build up in the body. That change lasts while fostamatinib is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
Who is at higher risk from the Lomitapide and Fostamatinib interaction?
The interaction record names this group as more likely to be affected:
- People taking higher doses
If this describes you, tell your pharmacist or prescriber.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Lomitapide and Fostamatinib Interaction
Ask in your own words about taking Lomitapide and Fostamatinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: JUXTAPID® oral capsules, lomitapide oral capsules. Chiesi USA, Inc. (per Manufacturer), Cary, NC, 2026. DailyMed
Other Serious Interactions of Lomitapide and Fostamatinib
Also serious with Lomitapide
- Ketoconazole TopicalContraindicated
- LefamulinContraindicated
- Lenacapavir OralContraindicated
- Letermovir InjectionContraindicated
Also serious with Fostamatinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Lomitapide
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin EModerate
- Vitamin AModerate
- + 164 more
With Fostamatinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin EModerate
- Vitamin AModerate
- + 205 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.